Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
DaVita Inc.

DaVita Inc. (DVA) Stock Overview

Explore DaVita Inc.’s financial performance, market position, analyst ratings, and future outlook.

DVA●NYSE
HealthcareMedical - Care Facilities
$173.82
$1.42(0.81%)
U.S. Market opens in 59h 50m

DaVita Inc. (DVA)

Meyka AI Score

Z

Key Financials

Market Cap11.2B
P/E Ratio15.05
EPS (TTM)$12.80
ROE-1.24%
Fundamental Analysis

AI Price Forecasts

1 Month$166.19
3 Months$198.50
1 Year Target$165.57

DVA Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of DaVita Inc. (NYSE: DVA) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, DaVita Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of DVA on the NYSE shows an RSI of 24.26, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $165.57 for the NYSE listing.

Key metrics behind DaVita Inc.'s NYSE-traded stock include a P/E ratio of 15.05 and a market capitalization of 11.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of DVA on the NYSE.

Price Performance (NYSE: DVA)

1-Day Change
-0.82%
5-Day Change
-2.90%
1-Month Change
-26.75%
3-Month Change
-12.51%
6-Month Change
15.31%
Year-to-Date (YTD) Change
52.98%
1-Year Change
26.33%
3-Year Change
70.58%
5-Year Change
31.24%
All-Time (Max) Change
4165.15%

Contact Information

https://www.davita.com
720 631 2100
2000 16th Street, Denver, CO, 80202

Company Facts

780,000 Employees
IPO DateOct 31, 1995
CountryUS
Actively Trading

Frequently Asked Questions